The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the launch of the TCT MedTech Innovation Forum, a summit dedicated to advances in medtech.
The Forum will run prior to the main sessions of the 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Boston, USA), the annual scientific symposium of CRF.
CRF describes the TCT MedTech Innovation Forum as an “intensive interactive summit”, which it says will bring together clinicians, entrepreneurs, investors, payors, and regulators to identify clinical challenges, uncover opportunities for innovation, and drive a practical understanding of the rewards and complex process required to bring novel medical technologies to market.
The intent is to shape the future of patient care and MedTech innovation through informed discussion, debate, and real-world insight, CRF says.
“We are thrilled to partner with Fogarty Innovation to create a world-class forum with the goal of inspiring and driving innovation forward to improve the quality, accessibility, and cost of delivering cardiovascular care,” said Juan F Granada, president and chief executive officer of CRF. “We are committed to bringing the latest medical breakthroughs to physicians and their patients as quickly as possible. This forum will convene like-minded individuals with a collective vision, passion, and purpose in a stimulating environment that fosters networking, promotes collaborations, and sparks novel ideas which are essential to driving innovation and improving healthcare.”
“TCT is the premier gathering for practitioners and researchers in interventional cardiovascular medicine,” said Andrew Cleeland, chief executive officer of Fogarty Innovation. “Bringing these clinicians together with stakeholders from across the ecosystem is critical to advancing medtech innovation. In keeping with Fogarty Innovation’s mission, we anticipate facilitating collaborations to foster novel solutions which will transform care for patients everywhere.”
The Forum will offer multiple formats for audience engagement. Presenters and panel discussants will share interdisciplinary perspectives and evaluate emerging trends in medtech innovation, encompassing digital health, health policy and equity, clinical challenges, financing, regulatory and reimbursement policy, and evolving healthcare delivery models.
Source CardiovascularNews
Duc Tin Clinic
Tin tức liên quan
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389